Form 4: BioLife Solutions Executive Sean Werner Sells Shares to Cover Tax Obligations

Sean Werner, Chief Technology Officer of BioLife Solutions, sold shares of common stock on March 3rd and 4th, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

• Sean Werner, the Chief Technology Officer of BioLife Solutions, executed sales of common stock on March 3rd and 4th, 2025.
• These transactions were conducted under pre-arranged Rule 10b5-1 trading plans.
• The sales were intended to cover tax withholding obligations associated with the vesting of restricted stock.
• On March 3rd, 2025, 136 shares were sold at a price of $25.46 per share.
• On March 4th, 2025, 88 shares were sold at a price of $24.03 per share.
• Following these transactions, Werner directly owns 4,865 shares of BioLife Solutions common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports stock sales for tax purposes, which is a routine event. There's no indication of positive or negative implications for the company's performance.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax planning. The use of a 10b5-1 plan indicates that these sales were pre-planned and not based on insider information.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the slight dilution of shares, but the impact is likely minimal given the relatively small number of shares sold.

Key Dates